Member Exclusive
Chronic heart failure clinical trial: mesenchymal stem cell therapy safety & viability reported
A Phase IIa clinical trial utilizing intravenous administration of mesenchymal stem cells in cardiac patients has reported positive safety and efficacy results.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Sign up today!
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>
No comments yet.